Buscar resultados de ensayos clínicos
Seminoma - 65 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors Condición: Non-seminomatous Germ-cell Tumors Fecha: 2014-04-10 Intervenciones: Drug: Cabazitaxel On Day 1 of each cycle, patients will receive cabazitaxel at a dose of 25 mg/m², |
Active, not recruiting |
Nombre del estudio: Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours Condición: Stage I Testicular Non-Seminomatous Germ Cell Tumor Fecha: 2012-11-09 Intervenciones: Drug: BEP(500) One cycle of BEP(500): |
Active, not recruiting |
Nombre del estudio: Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors Condición: Germ Cell Tumor Fecha: 2005-08-03 Intervenciones: Drug: gemcitabine, ifosfamide, cisplatin, G-CSF |
Recruiting |
Nombre del estudio: Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy Condición:
Fecha: 2014-08-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Condición:
|
Completed |
Nombre del estudio: Positron Emission Tomography in Detecting Testicle Cancer Condición: Testicular Germ Cell Tumor Fecha: 2002-09-06 Intervenciones:
|
Completed |
Nombre del estudio: Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer Condición: Testicular Germ Cell Tumor Fecha: 2007-11-02 Intervenciones:
|
Completed |
Nombre del estudio: Diagnostic Study of Patients With Stage I Testicular Cancer Condición: Testicular Germ Cell Tumor Fecha: 1999-11-01 Intervenciones:
|
Recruiting |
Nombre del estudio: First Line TIP in Poor Prognosis TGCTs. Condición: Germ Cell Tumor Fecha: 2015-04-08 Intervenciones:
|
Recruiting |
Nombre del estudio: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors Condición:
Intervenciones: Drug: Brentuximab Vedotin Both cohorts will be treated similarly and in parallel but analyzed separately |